03/17/2020 /
This model may be useful in better understanding the seizure count fluctuations seen in patients in other clinical settings.
03/17/2020 /
This month’s research highlights feature promising work by former CURE Grantees and CURE partners on SUDEP, treatment-resistant epilepsy, and more.
03/16/2020 /
This will also allow people to receive the RNS System before committing to an irreversible surgery such as laser ablation, while keeping their future treatment options open.
03/13/2020 /
This is the first study to explore the role of the amygdala and loss of breathing in children with epilepsy.
03/13/2020 /
Tests of extracts from plants used in ancient remedies led to one compound, derived from a magnolia tree, which could quell drug-resistant seizures in both fish and mice.
03/13/2020 /
The Phase 2b StATES study of Staccato® alprazolam met its primary endpoint which was proportion of responders achieving cessation of seizure activity within two minutes of treatment administration and no recurrence within two hours.
03/11/2020 /
The Bordey lab reports the elevated expression of actin-cross linking protein filamin A in the brain tissue of many patients with two genetic disorders linked to intractable seizures: tuberous sclerosis complex and a subset of focal cortical dysplasia type II.
03/06/2020 /
Clearer guidance will enhance clinicians’ confidence in communicating person centered epilepsy risk with people with epilepsy and their families thus improving outcomes.
03/06/2020 /
According to the researchers, this study reveals signs of inflammation, neuronal damage and transitory disruption of blood brain barrier following single generalized convulsive seizures.
